Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Head and Neck Neoplasms 22Squamous Cell Carcinoma of Head and Neck 19Melanoma 10Uterine Cervical Neoplasms 9Anus Neoplasms 8Ovarian Neoplasms 7Neoplasm Metastasis 7Carcinoma, Non-Small-Cell Lung 7Nasopharyngeal Carcinoma 6Vaginal Neoplasms 5Thyroid Neoplasms 5Stomach Neoplasms 5Penile Neoplasms 5Oropharyngeal Neoplasms 5Neoplasms 5Carcinoma, Renal Cell 5Breast Neoplasms 5Recurrence 4Pancreatic Neoplasms 4Esophageal Neoplasms 4Carcinoma, Transitional Cell 4Carcinoma, Squamous Cell 4Carcinoma, Merkel Cell 4Carcinoma, Hepatocellular 4Vulvar Neoplasms 3Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma 3Mouth Neoplasms 3Lung Neoplasms 3

Interventions

temsirolimus 1pembrolizumab 1niraparib 1atezolizumab 1Valproic Acid 1Tissue Banks 1Sirolimus 1Immunoglobulin G 1GSK-3326595 1Etoposide 1Disulfides 1Cyclophosphamide 1Cetuximab 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × Cyclophosphamide × Head & Neck × Clear all
NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Terminated
12 enrolled
DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡